| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/25/2002 | CA2434156A1 Sustained release drug delivery devices |
| 07/25/2002 | CA2430577A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | CA2430554A1 Intravascular blood conditioning device and use thereof |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1224940A1 Liquid interferon-beta formulations |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224937A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 07/24/2002 | EP1224929A2 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP1224924A2 Mixture for the treatment of inflammatory dental diseases and for use as a dental canal filler |
| 07/24/2002 | EP1224715A1 Coaxial connector having detachable locking sleeve |
| 07/24/2002 | EP1224279A2 Microbe, microbial exopolysaccharide, and uses thereof |
| 07/24/2002 | EP1224203A2 Antisense modulation of protein kinase c-theta expression |
| 07/24/2002 | EP1224202A1 Antisense modulation of integrin-linked kinase expression |
| 07/24/2002 | EP1224188A2 A salt of morphine |
| 07/24/2002 | EP1224004A1 Implantable vascular access device |
| 07/24/2002 | EP1223990A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223985A2 Dialysis solution including polyglycol osmotic agent |
| 07/24/2002 | EP1223981A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 07/24/2002 | EP1223978A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 07/24/2002 | EP1223975A2 MUCOSAL DTPa VACCINES |
| 07/24/2002 | EP1223972A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223960A2 Pharmaceutical agent preparations |
| 07/24/2002 | EP1223951A1 Method of preventing adhesions with absorbable polyoxaesters |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223949A1 Extended release formulations of erythromycin derivatives |
| 07/24/2002 | EP1223936A1 Oral formulations for anti-tumor compounds |
| 07/24/2002 | EP1223925A2 Use of a fatty acid derivative for the treatment of external secretion disorders |
| 07/24/2002 | EP1223920A1 Edible mcc/pga coating composition |
| 07/24/2002 | EP1223919A1 Swellable delivery system |
| 07/24/2002 | EP1223918A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 07/24/2002 | EP1223917A1 Sustained release microspheres |
| 07/24/2002 | EP1223916A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1223914A2 Orally distintegrating composition comprising mirtazapine |
| 07/24/2002 | EP1223802A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 07/24/2002 | EP1146896B1 Monodisperse hexameric acylated insulin analog formulations |
| 07/24/2002 | EP1117356A4 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/24/2002 | EP1089716B1 Ingestible elements |
| 07/24/2002 | EP1035841B1 Method for producing solid dosing forms |
| 07/24/2002 | EP0938316B1 Galenic composition containing opioid antagonists |
| 07/24/2002 | EP0935616B1 Adhesives with low level of residual monomers and process for manufacturing same |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | EP0882085B1 Biodegradable polymer networks for use in orthopedic and dental applications |
| 07/24/2002 | EP0874632B1 High-content famciclovir tablets |
| 07/24/2002 | EP0855907B1 Composition for transdermal delivery |
| 07/24/2002 | EP0799030B1 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP0760809B1 Application of omega-hydrofluoroalkyl ethers |
| 07/24/2002 | EP0758886B1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
| 07/24/2002 | EP0744942B1 Controlled release hydrogel formulation |
| 07/24/2002 | EP0742011B1 Percutaneously absorbable preparation |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | EP0674497B1 Microporous macrocapsules |
| 07/24/2002 | CN2501505Y Far infrared magnetic health-care patch |
| 07/24/2002 | CN1360612A Film coatings and film coating compositions based on polyvinyl alcohol |
| 07/24/2002 | CN1360611A Neutral lipopolymer and liposomal compositions contg. same |
| 07/24/2002 | CN1360506A Growth hormone formulations |
| 07/24/2002 | CN1360505A Pseudomycin antifungal compositions and method for their use |
| 07/24/2002 | CN1360504A Taste masked pharmaceutical liquid formulations |
| 07/24/2002 | CN1360499A Pharmaceutical composition contg. fenofibrate and preparation method |
| 07/24/2002 | CN1360497A Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 07/24/2002 | CN1360496A Dry powder compositions |
| 07/24/2002 | CN1360495A Intravaginal clindamycin ovule composition |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360491A Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 07/24/2002 | CN1360490A Method and apapratus for mfg. dissolvable tablets |
| 07/24/2002 | CN1360467A Antimicrobial sanitizing lotion with skin protection properties |
| 07/24/2002 | CN1359719A Application of tea in preparing exterior-applied medicine of treating dermatopathy |
| 07/24/2002 | CN1359717A Process for prepairng Chinese-medicinal ointment of treating uremia, renal hypertension and hyperlipomia |
| 07/24/2002 | CN1359715A Process for preparing antalgic thermotherapeutic medicine |
| 07/24/2002 | CN1359712A Powdered Chinese medicine for treating burn and scald |
| 07/24/2002 | CN1359709A Process for extracting active component from cassia seed |
| 07/24/2002 | CN1359704A Process for preparing patch for treatment of cervicodynia |
| 07/24/2002 | CN1359698A Nano gynostemma pentaphyllum |
| 07/24/2002 | CN1359690A Chinese-medicinal ointment for treating mastopathy |
| 07/24/2002 | CN1359687A Medicine for treating cardiovascular and cerebrovascular infarction |
| 07/24/2002 | CN1359683A Bactericidal liquid for intramuscular injection, intravenous injection and mixing with blood |
| 07/24/2002 | CN1359681A Mometasone furoate as nasal spray and its preparing process |
| 07/24/2002 | CN1359680A Prescription of preparing moxapride citrate |
| 07/24/2002 | CN1359677A Preparation of propofol with enhanced bacteria inhibition |
| 07/24/2002 | CN1359637A Health-care chewing vegetable tablet and its preparing process |
| 07/24/2002 | CN1088075C Polymer film composition for capsules |
| 07/24/2002 | CN1087940C Brain protein hydrolysate |
| 07/24/2002 | CN1087939C 碘酸钾制剂 Preparation of potassium iodate |
| 07/24/2002 | CN1087938C 东莨菪碱膏药 Scopolamine plaster |
| 07/24/2002 | CN1087933C Encapsulated medicine |
| 07/24/2002 | CN1087932C Proliposome powder for inhalation |
| 07/23/2002 | US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores |
| 07/23/2002 | US6423749 Pharmaceutical composition for injection based on paracetamol |
| 07/23/2002 | US6423743 Analyzing for gene for expression of procyanidin |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423697 Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm |
| 07/23/2002 | US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/23/2002 | US6423351 Inhibiting oxidative degradation of pharmaceutical formulations |
| 07/23/2002 | US6423346 Fish gelatinous composition for use as an ingredient in tablets |
| 07/23/2002 | US6423345 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 07/23/2002 | US6423344 Dispersion of dry powders, atomizing, drying and accumulation of particles |